BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Deals

  Mallinckrodt plc Reports Strong Fourth Quarter and Total Company 2018 Results, Announces 2019 Guidance and Strategic Priorities

  Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, reported results for the three months and fiscal year ended Dec. 28, 2018.

  February 26, 2019

   · 

  34 min read
• Pharm Country

  Teleflex to Present at Barclays Global Healthcare Conference

  Liam Kelly, President and Chief Executive Officer, Teleflex Incorporated, is scheduled to speak at Barclays Global Healthcare Conference at the Loews Miami Beach Hotel in Miami Beach, Florida, on Tuesday, March 12, 2019 at 8:00 am.

  February 26, 2019

   · 

  1 min read
• Drug Development

  LYNPARZA® (olaparib) Reduced the Risk of Disease Progression or Death as 1st-Line Maintenance Treatment in Germline BRCA-Mutated Metastatic Pancreatic Cancer

  AstraZeneca and Merck’s LYNPARZA is the first PARP inhibitor to demonstrate benefit in gBRCAm metastatic pancreatic cancer in a Phase III Trial

  February 26, 2019

   · 

  14 min read
• Alkermes Initiates Clinical Study of ALKS 4230 Administered Subcutaneously in Patients With Advanced Solid Tumors

  Once-Weekly and Once-Every-Three-Week Dosing of ALKS 4230 to be Evaluated as Monotherapy and in Combination With Pembrolizumab

  February 26, 2019

   · 

  6 min read
• Business

  Blueprint Medicines Reports Fourth Quarter and Full Year 2018 Financial Results

  Blueprint Medicines Corporation reported financial results and provided a business update for the fourth quarter and full year ended December 31, 2018.

  February 26, 2019

   · 

  11 min read
• Deals

  Fresenius Medical Care completes acquisition of NxStage Medical

  Fresenius Medical Care, the world’s largest provider of dialysis products and services, has successfully completed the acquisition of NxStage Medical, Inc., following approval by antitrust authorities in the United States.

  February 26, 2019

   · 

  4 min read
• Policy

  Trio Health Highlights Real World Evidence Outcomes from Studies of HCV, Hemophilia, and HIV

  Research closely parallels FDA’s guidance for incorporating real world evidence into its regulatory oversight

  February 26, 2019

   · 

  5 min read
• Job Trends

  Fifth Graders in Oregon Districts Using STEMscopes NGSS Digital Science Curriculum Achieve Higher Proficiency Rates on State Science Assessment

  In 2018, Oregon school districts that used the STEMscopes™ NGSS digital science curriculum with their fifth grade students showed higher proficiency rates on the state science assessment than districts that did not use STEMscopes, according to a new study published by Accelerate Learning.

  February 26, 2019

   · 

  2 min read
• Business

  Omeros Corporation to Announce Fourth Quarter and Year-End 2018 Financial Results on March 1, 2019

  Omeros Corporation, announced that the company will issue its fourth quarter and year-end 2018 financial results for the period ended December 31, 2018, on Friday, March 1, 2019, before the market opens.

  February 26, 2019

   · 

  2 min read
• Business

  Asana BioSciences Strengthens Leadership Team as ASN002 Phase 2b RADIANT Trial in Atopic Dermatitis Advances with a Second Positive DSMB Recommendation

  Appointment of Shashank Mahashabde as VP of CMC and Pablo Jimenez, MD FAPCR as VP and Therapeutic Area Head of Immunology

  February 26, 2019

   · 

  4 min read